Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Small-cap biotech names are gaining attention as clinical readouts and medical conference updates shape market sentiment ...

IBB, one of the largest exchange-traded funds focused on biotechnology, manages approximately $8.28 billion in assets and ...

Biotech ETFs are surging in 2026 as a friendlier FDA, strong M&A activity and AI-driven drug discovery fuel optimism for more ...

Ricks has led a $50 billion manufacturing Marshall Plan in pharma to safeguard Lilly’s lead in obesity and diabetes treatments. Gene therapy maker uniQure is one step closer to marketing its treatment ...

Clinical-stage biotech and diagnostics names draw attention as risk appetite broadens toward therapy, testing, and ...

Butterfly Network (NYSE: BFLY) soars 33% to a 52-week high after Midjourney Medical announces a full-body ultrasound scanner ...

Company to Loan $6.5 Million Prior to Closing to Fund Order Backlog and Working Capital Needs – Combined Company to be Renamed NOMAD Power ...

On June 4, 2026, CNBC reported that global biopharma M&A is on track for its strongest year since the pre-pandemic peak seven years ago.

IceCure Medical (Nasdaq: ICCM) stock surges intraday as the company reports 70% growth in its active U.S. ProSense install ...

Detailed price information for Purple Biotech Ltd ADR (PPBT-Q) from The Globe and Mail including charting and trades.